|
05 Apr 2025 |
Emcure Pharma
|
Consensus Share Price Target
|
987.40 |
1535.00 |
- |
55.46 |
buy
|
|
|
|
|
03 Jul 2024
|
Emcure Pharma
|
Hem Securities
|
987.40
|
|
|
|
IPO Subscribe
|
|
|
|
|
02 Jul 2024
|
Emcure Pharma
|
HDFC Securities
|
987.40
|
|
|
|
IPO Note
|
|
|
Issue Snapshot: Issue Open: July 03 July 05, 2024 Price Band: Rs. 960 1008 (Discount of Rs 90 per sh for all eligible employees) *Issue Size: Up to Rs 1952.0 cr (Fresh issue up to Rs 800 cr + Offer for sale of up to 11,428,839 eq sh including employee reservation of upto 108,900 eq sh) Reservation for: QIB upto 50% eq sh Non-Institutional atleast 15% eq sh ((including 1/3rd for applications between Rs.2 lakhs to Rs.10 lakhs)) Retail atleast 35% eq sh Face Value: Rs 10 Book value: Rs 163.22 (March 31, 2024) Bid size: - 14 equity shares and in multiples thereof 100% Book built Issue IPO Note-Emcure Pharmaceuticals Limited-03072024
|
|
02 Jul 2024
|
Emcure Pharma
|
Ashika Research
|
987.40
|
|
|
|
IPO Note
|
|
|
|
|
02 Jul 2024
|
Emcure Pharma
|
KRChoksey
|
987.40
|
|
|
|
IPO Note
|
|
|
EMCURE PHARMACEUTICALS LIMITED, was founded in 1981 by Mr. Satish Mehta, at Pune, India and is the 13th largest pharmaceuticals company from India based on MAT sales, for the domestic market, for FY24. The company exports its products in over 70 countries and has a strong presence in India, Europe, and Canada.
|
|
02 Jul 2024
|
Emcure Pharma
|
SBI Securities
|
987.40
|
|
|
|
IPO Subscribe
|
|
|
|
|
02 Jul 2024
|
Emcure Pharma
|
Ventura
|
987.40
|
|
|
|
IPO Subscribe
|
|
|
|